Is serum hyaluronan a helpful tool in the management of patients with liver diseases?

23Citations
Citations of this article
12Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

The results of serial determinations of serum hyaluronan indicate a prognostic value in progressive liver damage. In primary biliary cirrhosis and in cirrhotic alcoholic liver diseases serum hyaluronan level discriminates between early and advanced disease. In alcoholic liver disease serum hyaluronan can be applied as assessment of haemodynamic changes. Serum hyaluronan is of use as a non-invasive index of liver fibrosis in chronic viral hepatitis. A reversible defect in the hyaluronan receptor of the hepatic endothelial cells was suggested following studies on paracetamol- induced acute liver damage. In liver transplantation, graft function can be predicted by determination of the venous effluent of hyaluronan.

Author supplied keywords

Cite

CITATION STYLE

APA

Lindqvist, U. (1997). Is serum hyaluronan a helpful tool in the management of patients with liver diseases? In Journal of Internal Medicine (Vol. 242, pp. 67–71). Blackwell Publishing Ltd. https://doi.org/10.1046/j.1365-2796.1997.00176.x

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free